GE Healthcare Technologies (GEHC) is seeing a mix of investor activity related to buy and sell positions. Institutions such as
Strs Ohio,
Teacher Retirement System of Texas,
Allstate Corp,
Locust Wood Capital Advisers LLC, and
Nippon Life Global Investors Americas Inc. have boosted their shares in GEHC, even as others like
Massachusetts Financial Services Co. MA and
Commonwealth Equity Services LLC are reducing holdings. The company's market performance has been fluctuating, with an overall 7% year loss despite a recent 10.8% rise. This instability is amidst the announcement of a new Edge AI partnership with
NXP, and other various AI and software ventures, potentially reshaping GEHC's long-term competitive stance. The organization is also attracting attention with its decision to acquire
Intelerad for $2.3 billion, thereby extending into the outpatient care market. Though UBS subsequently downgraded the company to 'Sell', others like
Stifel Nicolaus maintain a 'Buy' rating. GEHC's recent launch of advanced
imaging solutions equipped with
NVIDIA technology should positively impact clinical workflows and enhance timely diagnoses.
Ge Healthcare Technologies GEHC News Analytics from Tue, 13 May 2025 07:00:00 GMT to Sat, 24 Jan 2026 12:08:39 GMT -
Rating 3
- Innovation 8
- Information 6
- Rumor -2
